1. Home
  2. GERN vs FCPT Comparison

GERN vs FCPT Comparison

Compare GERN & FCPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GERN
  • FCPT
  • Stock Information
  • Founded
  • GERN 1990
  • FCPT 2015
  • Country
  • GERN United States
  • FCPT United States
  • Employees
  • GERN N/A
  • FCPT 543
  • Industry
  • GERN Biotechnology: Pharmaceutical Preparations
  • FCPT Real Estate Investment Trusts
  • Sector
  • GERN Health Care
  • FCPT Real Estate
  • Exchange
  • GERN Nasdaq
  • FCPT Nasdaq
  • Market Cap
  • GERN 2.5B
  • FCPT 2.7B
  • IPO Year
  • GERN 1996
  • FCPT N/A
  • Fundamental
  • Price
  • GERN $3.34
  • FCPT $27.65
  • Analyst Decision
  • GERN Strong Buy
  • FCPT Buy
  • Analyst Count
  • GERN 10
  • FCPT 6
  • Target Price
  • GERN $7.05
  • FCPT $30.60
  • AVG Volume (30 Days)
  • GERN 8.0M
  • FCPT 692.3K
  • Earning Date
  • GERN 11-07-2024
  • FCPT 02-12-2025
  • Dividend Yield
  • GERN N/A
  • FCPT 4.99%
  • EPS Growth
  • GERN N/A
  • FCPT N/A
  • EPS
  • GERN N/A
  • FCPT 1.07
  • Revenue
  • GERN $29,480,000.00
  • FCPT $264,880,000.00
  • Revenue This Year
  • GERN $32,021.10
  • FCPT N/A
  • Revenue Next Year
  • GERN $298.14
  • FCPT $7.67
  • P/E Ratio
  • GERN N/A
  • FCPT $25.84
  • Revenue Growth
  • GERN 9199.68
  • FCPT 9.08
  • 52 Week Low
  • GERN $1.64
  • FCPT $22.38
  • 52 Week High
  • GERN $5.34
  • FCPT $30.93
  • Technical
  • Relative Strength Index (RSI)
  • GERN 25.88
  • FCPT 40.77
  • Support Level
  • GERN $3.75
  • FCPT $26.58
  • Resistance Level
  • GERN $4.00
  • FCPT $28.48
  • Average True Range (ATR)
  • GERN 0.17
  • FCPT 0.57
  • MACD
  • GERN -0.06
  • FCPT -0.20
  • Stochastic Oscillator
  • GERN 7.41
  • FCPT 36.90

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About FCPT Four Corners Property Trust Inc.

Four Corners Property Trust Inc is a real estate investment trust predominantly engaged in the ownership, acquisition and leasing of restaurant and retail properties. The company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries. The firm operates through two segments namely, real estate operations and restaurant operations. The real estate operations segment consists of rental revenues generated by leasing restaurant and retail properties to tenants. The restaurant operations segment is conducted through a taxable REIT subsidiary (TRS) and consists of Kerrow Restaurant Operating Business. The firm generates majority of the revenue from the real estate operations segment.

Share on Social Networks: